Home
Tessera Therapeutics

Tessera Therapeutics Market Share Analysis for November 2025

Pioneering Gene Writing™, a new biotechnology designed to offer the ability to make almost any change to the genome curing diseases at their source.

Health > Biotechnology and Pharmaceuticals

Domaintesseratherapeutics.com

Year Founded2018

Employees201 - 500

Annual Revenue$5M - $10M

Tessera Therapeutics

Tessera Therapeutics (including company regionals)

tesseratherapeutics.com

See more website traffic and engagement information

Tessera Therapeutics Revenue up to November 2025 is 5M - 10M

revenue generated by Tessera Therapeutics top domains

Tessera Therapeutics top domains revenue over 3 years

Revenue for Tessera Therapeutics top domains

tesseratherapeutics.com5M - 10M

See more with Sales Intelligence

Total visits to Tessera Therapeutics's top domains

Understand Tessera Therapeutics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

tesseratherapeutics.com4.8K

See more with Sales Intelligence

Avg. visit duration in Tessera Therapeutics's top domains

Analyze Tessera Therapeutics engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

tesseratherapeutics.com00:00:36

See more with Sales Intelligence

Avg. pageviews on Tessera Therapeutics's top domains

See how Tessera Therapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

tesseratherapeutics.com2.41

See more with Sales Intelligence

Tessera Therapeutics top competitors by domain

Top similar sites in November 2025, ranked by their affinity

dewpointx.comCompany NameDewpoint Therapeutics, Inc.Employees51 - 200HQUnited States, Massachusetts, BostonAnnual revenue$10M - $15MTotal visits5.2KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Tessera Therapeutics

These are the website technologies, by industry, used by Tessera Therapeutics top domains

Advertising (4)

Google Adsense

Content Management System (2)

Web Dot Com

Mobile (2)

Meta Viewport

Conversion & Analytics (1)

Google Analytics

More Technologies

4

See all

News & Signals from Tessera Therapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsTessera Therapeutics, Inc. is developing TSRA-196.Regeneron Pharmaceuticals has teamed up with Tessera Therapeutics to develop and commercialise Tessera's rare disease in vivo gene writing programme, TSRA-196.

NewsTessera Therapeutics, Inc. is developing gene editing treatment for alpha-1 antitrypsin deficiency.Summary Regeneron Pharmaceuticals has announced a partnership with Tessera Therapeutics to develop a gene editing treatment for alpha-1 antitrypsin deficiency (AATD), a rare liver and lung disease.

NewsRegeneron will partner with Tessera Therapeutics, Inc. on Dec 8th '25.Regeneron Pharmaceuticals is putting more money into gene editing, announcing Monday a partnership with Tessera Therapeutics to develop an experimental program for a rare liver and lung disease.